2024
Farrokhi A, Atre T, Salitra S, Aletaha M, Marquez C, Gynn M, Fidanza M, Jo S, Rolf N, Simmons K, Duque-Afonso J, Cleary ML, Seif AE, Gantt S,Kollmann T, and Reid GSD. (2024) Early-life infection induces depletion of preleukemic cells in a mouse model of hyperdiploid B-cell acute lymphoblastic leukemia. Blood, Jun 14: 2024025038 (PMID: 38875504)
Farrokhi A, Atre T, Rever J, Fidanza M, Duey W, Salitra S, Myung J, Guo M, Jo S, Uzozie A, Baharvand F, Rolf N, Auer F, Hauer J, Seif AE, Grupp SA, Eydoux P, Lange PF, Maxwell CA, and Reid GSD. (2024) The Em-Ret mouse is a novel model of hyperdiploid B-cell acute lymphoblastic leukemia. Leukemia, doi: 10.1038/s41375-024-02221-x (PMID: 38519798)
2023
Lorentzian AC, Rever J, Ergin EK, Guo M, Akella NM, Rolf N, James Lim C, Reid GSD, Maxwell CA, Lange PF. (2023) Targetable lesions and proteomes predict therapy sensitivity through disease evolution in pediatric acute lymphoblastic leukemia. Nature Communications;14(1):7161. (PMID: 37989729)
Atre T, Farrokhi A, Jo S, Salitra S, Duque-Afonso J, Cleary ML, Rolf N, Reid GSD. (2023) Age and ligand specificity influence the outcome of pathogen engagement on preleukemic and leukemic B-cell precursor populations. Blood Advances;7(22):7087-7099. (PMID: 37824841)
Rahavi SM, Aletaha M, Farrokhi A, Lorentzian A, Lange PF, Maxwell CA, Lim CJ, and Reid GSD. (2023) Adaptation of the Th-MYCN mouse model of neuroblastoma for evaluation of disseminated disease. Int. J. Mol. Sci., 24(15), 12071. (PMID: 37569447)
2021
Rolf N, Liu LYT, Tsang A, Lange PF, Lim CJ, Maxwell CA, Vercauteren SM, Reid GSD. (2021) A cross-standardized analytical flow cytometry platform to assess phenotypic stability and compare subpopulation complexity in matched patient- and xenograft-derived B-ALL samples. Cytometry A. doi: 10.1002/cyto.a.24473. (PMID: 34128309)
Uzozie A, Ergin E, Rolf N, Tsui J, Lorentzian A, Lim CJ, Maxwell C, Reid GS, Lange PF. (2021) PDX mouse models recapitulate the proteome landscape of pediatric acute leukemia but divert in select pathways. J Exp Clin Cancer Res 40, 96 (2021). (PMID: 33722259)
2020
Jo S, Fotovati A, Duque-Afonso J, Cleary ML, van den Elzen P, Seif AE, Reid GSD. (2020) Differential depletion of bone marrow resident B-ALL after systemic administration of endosomal TLR agonists. Cancers 12(1);169-183. (PMID: 32015298)
2018
Rolf N, Smolen KK, Kariminia A, Velenosi A, Fidanza M, Strahlendorf C, Seif AE, and Reid GS. (2018) Absolute lymphocyte counts at end of induction correlate with distinct immune cell compartments in pediatric B cell precursor acute lymphoblastic leukemia. Cancer Immunol Immunother 67: 225-236. (PMID: 29052781)
2017
Jo S, Lee JH, Mattei JJ, Barrett DM, van den Elzen P, Grupp SA, Reid GS, and Seif AE. (2017). Generation of a multi-antigen-directed immune response for durable control of acute lymphoblastic leukemia. Leukemia 32(2):539-542. (PMID: 28924244)
Fidanza M, Seif AE, Jo S, Kariminia A, Rolf N, Sly LM, Grupp SA, Reid GS. (2017) IFN-γ directly inhibits murine B-cell precursor leukemia-initiating cell proliferation early in life. European Journal of Immunology 47(5):892-899. (PMID: 28295300)
2016
Fidanza M, Seif AE, DeMicco A, Rolf N, Jo S, Yin B, Li Y, Barrett DM, Duque-Afonso J, Cleary ML, Bassing CH, Grupp SA, Reid GS. (2016) Inhibition of precursor B-cell malignancy progression by toll-like receptor ligand-induced immune responses. Leukemia 30(10): 2116-2119. (PMID: 27220664)